APOE2 Publications

APOE2 Model Page

Filter publications by application: All Alzheimer's Metabolism Neuroscience
Filter publications by model type: All Knock in Knock out

Author(s)

(Date)

Paper Title

Citation

Model Type

Applications

Full Text

Jo DH, et al.
Mouse over for full list
Jo DH, Lee JH, Jun HJ, Kim J, Wen Q, Hoang MH, Yu YS, Kim JH, Lee SJ
(2015) Gene expression profiles of primary retinal pigment epithelial cells from apolipoprotein E knockout and human apolipoprotein E2 transgenic mice. Genet. Mol. Res. 14(1):1855-67
Knock out, Knock in
Metabolism
Tagalakis AD, et al.
Mouse over for full list
Tagalakis AD, Graham IR, Riddell DR, Dickson JG, Owen JS
(2001) Gene correction of the apolipoprotein (Apo) E2 phenotype to wild-type ApoE3 by in situ chimeraplasty. J. Biol. Chem. 276(16):13226-30
Knock in
Metabolism, Neuroscience, Alzheimer's
Malek G, et al.
Mouse over for full list
Malek G, Johnson LV, Mace BE, Saloupis P, Schmechel DE, Rickman DW, Toth CA, Sullivan PM, Bowes Rickman C
(2005) Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration. Proc. Natl. Acad. Sci. U.S.A. 102(33):11900-5
Neuroscience
Knouff C, et al.
Mouse over for full list
Knouff C, Hinsdale ME, Mezdour H, Altenburg MK, Watanabe M, Quarfordt SH, Sullivan PM, Maeda N
(1999) Apo E structure determines VLDL clearance and atherosclerosis risk in mice. J. Clin. Invest. 103(11):1579-86
Gerritsen G, et al.
Mouse over for full list
Gerritsen G, Kypreos KE, van der Zee A, Teusink B, Zannis VI, Havekes LM, van Dijk KW
(2003) Hyperlipidemia in APOE2 transgenic mice is ameliorated by a truncated apoE variant lacking the C-terminal domain. J. Lipid Res. 44(2):408-14
Sullivan PM, et al.
Mouse over for full list
Sullivan PM, Mezdour H, Quarfordt SH, Maeda N
(1998) Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe*2. J. Clin. Invest. 102(1):130-5